Skip to main content
Clinical Trials/ITMCTR2024000118
ITMCTR2024000118
Not yet recruiting
Early Phase 1

Safety and effectiveness of electroacupuncture in the treatment of postoperative gastrointestinal dysfunction in patients with perioperative esophageal cancer: a prospective, randomized, and controlled clinical trial

The First Affiliated Hospital of Naval Medical University0 sitesTBD

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
The First Affiliated Hospital of Naval Medical University
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional study
Sex
All

Investigators

Sponsor
The First Affiliated Hospital of Naval Medical University

Eligibility Criteria

Inclusion Criteria

  • The study will include male or female patients of age 18–60 years; those diagnosed as having EC and will be undergoing elective surgery; those with American Society of Anesthesiologists (ASA) classification I–III \[33]; those without any previous history of thoracic or abdominal surgery; and those who have signed informed consent.

Exclusion Criteria

  • The study will exclude patients who had received epidural anesthesia, need to undergo other synchronized operations, had received drugs that affect the intestinal function within 1 month before the study, have intraoperative and postoperative complications and require long\-term intensive care (more than 24 h), have mental disorder or a history of opioid abuse, (6\) had received acupuncture treatment within 1 month before the study, had participated in other clinical studies 3 months before enrolling for this study, have severe hepatic and renal dysfunction, had undergone emergency reoperations, and have second\- or third\-degree heart blocks and tachyarrhythmias with a baseline heart rate of \<50 beats/min or have electrical stimulation devices (pacemakers or implantable defibrillators); those who experience gastrointestinal bleeding before operation (bleeding volume: 800 mL); and those with ASA classification IV or V (IV indicates that the patient has a severe systemic disease that poses an ongoing threat to life; V indicates that the patient is dying and is expected not to survive without surgery).

Outcomes

Primary Outcomes

Not specified

Similar Trials